ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-78 Cr | ₹-448 Cr | ₹-649 Cr | ₹-688 Cr | ₹-893 Cr |
What is the latest Total Non-Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹-78 Cr |
| Mar2025 | ₹-448 Cr |
| Mar2024 | ₹-649 Cr |
| Mar2023 | ₹-688 Cr |
| Mar2022 | ₹-893 Cr |
How is Total Non-Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-78 Cr | Negative | |
| Mar2025 | ₹-448 Cr | Negative | |
| Mar2024 | ₹-649 Cr | Negative | |
| Mar2023 | ₹-688 Cr | Negative | |
| Mar2022 | ₹-893 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹61,952.8 Cr | -4.6% | 2.5% | -10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -4.6% |
2.5% |
-10.8% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses